Risk of Treatment Failure and Death after Ablation in Hepatocellular Carcinoma Patients—A Multiparametric Prediction

SIMPLE SUMMARY: Patients with early-stage BCLC 0/A hepatocellular carcinoma (HCC) who are not candidates for liver transplantation or resection are treated with percutaneous ablation according to guidelines. Nevertheless, these patients are at high risk of HCC recurrence and physicians must apply di...

Descripción completa

Detalles Bibliográficos
Autores principales: Muñoz-Martínez, Sergio, Sapena, Victor, García-Criado, Ángeles, Darnell, Anna, Forner, Alejandro, Belmonte, Ernest, Sanduzzi-Zamparelli, Marco, Rimola, Jordi, Soler, Alexandre, Llarch, Neus, Iserte, Gemma, Mauro, Ezequiel, Ayuso, Carmen, Rios, Jose, Bruix, Jordi, Vilana, Ramon, Reig, María
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339895/
https://www.ncbi.nlm.nih.gov/pubmed/37444380
http://dx.doi.org/10.3390/cancers15133269

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339895/
https://www.ncbi.nlm.nih.gov/pubmed/37444380
http://dx.doi.org/10.3390/cancers15133269

Ejemplares similares